Sales 2024 * | 48.16B 45.13B | Sales 2025 * | 49.98B 46.83B | Capitalization | 204B 191B |
---|---|---|---|---|---|
Net income 2024 * | 10.65B 9.98B | Net income 2025 * | 11.58B 10.85B | EV / Sales 2024 * | 4.48 x |
Net Debt 2024 * | 12.16B 11.39B | Net Debt 2025 * | 10.8B 10.12B | EV / Sales 2025 * | 4.29 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
16.2
x | Employees | 76,057 |
Yield 2024 * |
3.93% | Yield 2025 * |
4.06% | Free-Float | 81.95% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+28.79% | 673B | |
+24.81% | 551B | |
-7.64% | 348B | |
+15.00% | 317B | |
+5.99% | 288B | |
+2.47% | 210B | |
-9.98% | 195B | |
-11.71% | 145B | |
-8.32% | 142B |